Castle Biosciences presented new data on DecisionDx-Melanoma at the 2026 EADV Congress, showing the test accurately identifies melanoma patients with low risk of sentinel lymph node (SLN) positivity and recurrence. In a study of 2,799 patients, those with low-risk test results had less than 5% SLN positivity and 99.6% five-year recurrence-free survival without undergoing SLNB. The test also identifies higher-risk early-stage patients who may benefit from closer monitoring. These findings support using DecisionDx-Melanoma to guide personalized treatment decisions and improve patient outcomes in melanoma care.
The DecisionDx-Melanoma test data from the 2026 EADV Congress offers insights into melanoma risk stratification. For readers following the Health sector, here is Pluang's market snapshot as of Oct 01, 2026 03:02 WIB: out of 100 priced US Health stocks, 30 rose and 69 fell. Notable movers include ENVB at USD 1.50 with a 3.45% increase and AMWL at USD 13.59 with a 3.42% increase but 100% sell order activity, alongside OSCR at USD 30.77 with a 3.36% rise and also 100% sell order activity.
Ferrovial and its DriveTN consortium have reached commercial close with the Tennessee Department of Transportation to finance, design, build, operate, and maintain the I-24 Southeast Choice Lanes in Nashville under a 50-year concession. This project,...
Fortinet is rated a Strong Buy due to its raised guidance and strong performance in data center markets. Its ASIC-powered firewalls offer 8–15 times higher throughput and 30–50% lower prices than competitors, driving rapid market share gains. Data ce...
The SUI token traded near $1.20 on Sept. 30 after the Sui network surpassed six billion transaction blocks, marking significant network activity. The token price rose from about $1 on Sept. 25 to nearly $1.29 on Sept. 27 before sellers pushed it down...
Emerita Resources Corp. has delayed the release of its Preliminary Feasibility Study (PFS) for the Iberian Belt West Project to conduct a more comprehensive technical and quality assurance review. The expanded review, initiated by the updated Board o...
The Sui blockchain has achieved a major milestone by processing over 6 billion transaction blocks, showcasing its high transaction speed and efficiency. Unlike typical blockchains, a single transaction block on Sui can include multiple actions bundle...
